Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
SEC Accession No. 0001206774-18-001976
Filing Date
2018-07-10
Accepted
2018-07-10 16:07:01
Documents
7

Document Format Files

Seq Description Document Type Size
1 PRE-EFFECTIVE AMENDMENT geron33139015-s3a.htm S-3/A 411006
2 OPINION OF COOLEY LLP geron33139015-ex51.htm EX-5.1 31977
3 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM geron33139015-ex231.htm EX-23.1 1720
4 GRAPHIC geron33139015-s3a1x4x1.jpg GRAPHIC 5094
5 GRAPHIC geron33139015-s3a4x4x1.jpg GRAPHIC 4335
6 GRAPHIC geron33139015-s3a6x1x1.jpg GRAPHIC 6856
7 GRAPHIC geron33139015-ex51.jpg GRAPHIC 8230
  Complete submission text file 0001206774-18-001976.txt   480188
Mailing Address 149 COMMONWEALTH DRIVE SUITE 2070 MENLO PARK CA 94025
Business Address 149 COMMONWEALTH DRIVE SUITE 2070 MENLO PARK CA 94025 6504737700
GERON CORP (Filer) CIK: 0000886744 (see all company filings)

EIN.: 752287752 | State of Incorp.: DE | Fiscal Year End: 1117
Type: S-3/A | Act: 33 | File No.: 333-225184 | Film No.: 18947038
SIC: 2834 Pharmaceutical Preparations